Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
E. Franceschi (Milan, Italy), B. Vigone (Milan, Italy), G. Sotgiu (Sassari, Italy), M. Gaffuri (Milan, Italy), A. Gramegna (Milan, Italy), C. Di Francesco (Milan, Italy), A. Gelmini (Milan, Italy), L. Saderi (Sassari, Italy), M. Dettori (Sassari, Italy), M. Seia (Milan, Italy), M. Mantero (Milan, Italy), P. Goeminne (Leuven, Belgium), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, Italy), F. Blasi (Milan, Italy). A broad immunological screening may impact treatment in bronchiectasis patients. 2881

Member's Comments

No comment yet.

Related content which might interest you: COPD detected with screening: impact on patient management and prognosis Source: Eur Respir J 2014; 44: 1571-1578 Year: 2014 The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 The clinical impact of adherence to therapy in airways disease Source: Breathe, 17 (2) 210039; 10.1183/20734735.0039-2021 Year: 2021 The impact of COVID-19 on patients with asthma Source: Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020 Year: 2021 Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002 A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Identifying patients with severe asthma that will be benefit from biological therapy Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 The psychological status of COPD patients: the impact of the long-term complex treatment and pulmonary rehabilitation Source: Eur Respir J 2003; 22: Suppl. 45, 53s Year: 2003 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Our clinical experience in surgical therapy of patients with bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 344s Year: 2002 Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 The impact of using different symptom-based exacerbation definitions in COPD patients Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 The bronchodilator response and clinical characteristics of patients with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 The effect of maintenance azithromycin on radiological features in patients with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients Source: Eur Respir J 2001; 18: 306-315 Year: 2001 The clinico-immunological evaluation of the ribomunyl therapy in complex treatment of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Prevelance and the association of anaemia with clinical and functional parameters in patients with COPD who referred to a pulmonary rehabilitation programme Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012